| 2017 ACC/AHA guideline | 2018 ESC/ESH guideline | ||
---|---|---|---|---|
Reference recommendations, No | Concordance, No. (%) | Reference recommendations, No | Concordance, No. (%) | |
Primary analysis | 59 | 30 (50.8) | 51 | 31 (60.8) |
Sensitivity analysis excluding insufficient ratings | 55 | 33 (60.0) | 49 | 32 (65.3) |
Sensitivity analysis excluding CPG originated from | ||||
 Malaysia | 59 | 30 (50.8) | 51 | 31 (60.8) |
 Brunei | 59 | 32 (54.2) | 51 | 33 (64.7) |
 Singapore | 59 | 30 (50.8) | 51 | 31 (60.8) |
 Thailand | 59 | 31 (52.5) | 51 | 32 (62.7) |
 Indonesia | 59 | 33 (55.9) | 51 | 34 (66.7) |
 Vietnam | 59 | 31 (52.5) | 51 | 32 (62.7) |